FOR CLINICIANS
RUNX1 and Inherited Hematologic Malignancies Consortium
Mission Statement
To define the prevalence and phenotypic spectrum of inherited platelet disorders with predisposition to hematologic malignancies, and to determine mechanisms and pathways influencing bleeding risk and subsequent progression to malignancies, with a goal of developing prevention and treatment strategies for patients.
This list of experts is available to both patients (please call for an appointment) and medical professionals for consultation. Scroll through and click on a clinician from the list or click on any marker on the map to view a clinician's details. If you are interested in joining this consortium, please click here to complete and submit the form.